Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Immunocore Holdings (IMCR) Operating Margin: 2021-2025

Historic Operating Margin for Immunocore Holdings (IMCR) over the last 3 years, with Sep 2025 value amounting to -6.92%.

  • Immunocore Holdings' Operating Margin rose 368.00% to -6.92% in Q3 2025 from the same period last year, while for Sep 2025 it was -11.88%, marking a year-over-year increase of 1108.00%. This contributed to the annual value of -22.71% for FY2024, which is 120.00% up from last year.
  • As of Q3 2025, Immunocore Holdings' Operating Margin stood at -6.92%, which was up 54.46% from -15.18% recorded in Q2 2025.
  • In the past 5 years, Immunocore Holdings' Operating Margin ranged from a high of 0.20% in Q4 2021 and a low of -37.57% during Q1 2024.
  • For the 3-year period, Immunocore Holdings' Operating Margin averaged around -19.50%, with its median value being -21.81% (2023).
  • Per our database at Business Quant, Immunocore Holdings' Operating Margin crashed by 1,069bps in 2024 and then soared by 3,372bps in 2025.
  • Quarterly analysis of 4 years shows Immunocore Holdings' Operating Margin stood at 0.20% in 2021, then reached -24.30% in 2023, then soared by 116bps to -23.14% in 2024, then skyrocketed by 368bps to -6.92% in 2025.
  • Its last three reported values are -6.92% in Q3 2025, -15.18% for Q2 2025, and -3.85% during Q1 2025.